Essential Partners’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$94.3K Sell
1,185
-34
-3% -$3.31K 0.04% 436
2026
Q2
$131K Sell
1,219
-2,471
-67% -$162K 0.06% 347
2026
Q1
$29.2K Buy
3,690
+1,662
+82% +$26.9K 0.01% 781
2025
Q4
$34.9K Buy
2,028
+2,021
+28,871% +$39.2K 0.01% 713
2025
Q3
$182 Sell
7
-30
-81% -$1.13K ﹤0.01% 2412
2025
Q2
$2.12K Buy
+37
New +$2.97K ﹤0.01% 1302

Other funds holding AGL

Essential Partners's AGL Position: Q3 2026 in Review

Essential Partners reduced its Agilon Health (AGL) stake by 2.8% in Q3 2026, selling an estimated $3.31K and leaving 1,185 shares worth $94.3K. The position accounts for 0.04% of the portfolio, ranked #436.

Essential Partners first reported a position in AGL in Q2 2025 and has held it in 6 quarters since. The position peaked at $131K in Q2 2026. 8 funds tracked by Wall St. Rank hold AGL as of Q3 2026.

  • Essential Partners held 1,185 shares of Agilon Health worth $94.3K as of Q3 2026.
  • Essential Partners sold 34 Agilon Health shares in Q3 2026, an estimated $3.31K.
  • Agilon Health made up 0.04% of Essential Partners's portfolio in Q3 2026, its #436 holding.
  • Essential Partners first reported a position in Agilon Health in Q2 2025 and has held it in 6 quarters since.
  • Essential Partners's Agilon Health position peaked at $131K in Q2 2026.
  • 8 funds tracked by Wall St. Rank held Agilon Health as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.